Experimental Survey on Percutaneous Injection of Calcium Phospate Cement in Preventing the Articular Surface Collapsing Secondary to Avascular Necrosis of Femoral Head

HOU Chang-long,Lü Wei-fu,ZHANG Xue-bin,WANG Wei-yu,ZHANG Xing-ming
DOI: https://doi.org/10.3969/j.issn.1008-794x.2007.06.013
2007-01-01
Abstract:Objective To study the technical way for animal model of ANFH with TAE(transcatheter arterial embolization)and to observe the image and pathologic changes of percutaneous injection with CPC(Calcium Phospate Cement)in prevening the articular surface collapsing secondary to ANFH(avascular necrosis of femoral head)in pigs and its feasibility and safety.Methods Branch arteries of the pig's left femoral head were embolized with woolly threads.Twenty pigs were randomly divided into A and B groups,and after about 1 month changes were assessed by imagings.Group A(n = 8)was sevend as contral of model contrast group,with only TAE and then surveried the avascular necrosis features of femoral head by imaging together with pathologic and histologic examinations.Group B(n = 12) was designated as percutaneous injection with CPC for interventional treatment group of ANFH at the stage Ficat Ⅱ.Results The animal models of ANFH in early stage were established by embolization of feeding arteries.In Group A,bone collapse occurred in 1.5 months after TAE,with imaging features of femoral head necrosis aggravated gradually.In group B,technical success of percutaneous injection with CPC was high and technical criteria included precise injection time,vigorous percutanous fixing of bone,suitable proportion of CPC powder to liquid.CT scan of femoral head with injection CPC showed that it diffused well.Volume of bone trabecula(TBV)and percentage of bone lacuna(PBL)at unit area under microscopy were also inspected in two groups.TBV and PBL of two groups were compared in different special times and calculated especially for group B(P 0.05).Conclusion The percutanous injection of CPC to femoral head is a quite safe and effective palliative therapy for ANFH in early stage.
What problem does this paper attempt to address?